Dapsone Export Market Intelligence: India's 96 Suppliers Shipping to 55 Countries — TransData Nexus 2026

Q: Who are the top dapsone exporters from India?

The top dapsone exporters from India are: 1. TORRENT PHARMACEUTICALS LTD — $11.3M (50.1% market share); 2. TORRENT PHARMACEUTICALS LIMITED — $5.0M (22.0% market share); 3. ALEMBIC PHARMACEUTICALS LIMITED — $2.5M (11.0% market share); 4. EMCURE PHARMACEUTICALS LIMITED — $1.9M (8.5% market share); 5. ENCUBE ETHICALS PRIVATE LIMITED — $541.6K (2.4% market share). Together they account for 94.0% of India's total dapsone export value.

Q: What is the total export value of dapsone from India?

The total export value of dapsone from India is $22.6M USD, recorded across 1,279 shipment transactions from 96 active exporters to 55 destination countries. The average shipment value is $17.7K.

Q: Which countries import dapsone from India?

India exports dapsone to 55 countries worldwide. The top importing countries are: UNITED STATES (86.8% share, $19.6M), CANADA (7.6% share, $1.7M), UNITED KINGDOM (2.1% share, $485.2K), VIETNAM (1.7% share, $393.7K), SOUTH AFRICA (0.8% share, $180.0K). These five markets account for 99.1% of total export value.

Q: What is the HS code for dapsone exports from India?

The primary HS code for dapsone exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of dapsone exports from India?

The average unit price for dapsone exports from India is $15.14 USD per unit, with prices ranging from $0.01 to $2813.46 depending on formulation, packaging, and order volume. The total market is valued at $22.6M across 1,279 shipments.

Q: Which ports handle dapsone exports from India?

The primary ports for dapsone exports from India are SAHAR AIR (34.5% of shipments), SAHAR AIR CARGO ACC (INBOM4) (18.5% of shipments), DELHI AIR CARGO ACC (INDEL4) (8.9% of shipments), Bombay Air (6.8% of shipments), DELHI AIR (5.7% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of dapsone?

India is one of the world's leading exporters of dapsone due to its large base of 96 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports dapsone to 55 countries, demonstrating 28% global market coverage.

Q: What certifications do Indian dapsone exporters need?

Indian dapsone exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import dapsone from India?

There are 178 registered buyers importing dapsone from India, spread across 55 countries. The repeat buyer rate is 60.7%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top dapsone supplier from India?

TORRENT PHARMACEUTICALS LTD is the leading dapsone exporter from India with a market share of 50.1% and total export value of $11.3M across 33 shipments. The top 5 suppliers together control 94.0% of total export value.

Suresh Sormare

Dapsone

India Pharmaceutical Trade Intelligence

$22.6M96 Suppliers55 CountriesHS 30049099

ExportsIndia → UNITED STATES86.8%India → CANADA7.6%

ImportsDENMARK → India$1.6B UNITED STATES → India$219.3K

#1 Buyer: TORRENT PHARMA

Dapsone Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Dapsone to the World

Between 2022 and 2026, India exported $22.6M worth of dapsone across 1,279 verified shipments to 55 countries — covering 28% of world markets in the Antimalarial & Antiparasitic segment. The largest destination is UNITED STATES (86.8%). TORRENT PHARMACEUTICALS LTD leads with a 50.1% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Dapsone export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Dapsone export data snapshot — $22.6M · 96 exporters · 55 countriesTransData Nexus · Indian Customs Data

Top Dapsone Exporters from India

96 active exporters · Ranked by export value

View all 96 →

Top Dapsone Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	TORRENT PHARMACEUTICALS LTD	$11.3M	33	2	50.1%
2	TORRENT PHARMACEUTICALS LIMITED

Top Countries Importing Dapsone from India

55 destination markets · Ranked by import value

All 55 countries →

Top Countries Importing Dapsone from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$19.6M	86.8%
2	CANADA	$1.7M	7.6%
3	UNITED KINGDOM	$485.2K	2.1%
4	VIETNAM	$393.7K	1.7%
5	SOUTH AFRICA	$180.0K	0.8%
6	SOMALIA	$70.8K	0.3%
7	TURKEY	$39.8K	0.2%
8	INDONESIA	$36.5K	0.2%
9	AFGHANISTAN	$12.9K	0.1%
10	UNITED ARAB EMIRATES	$8.5K	0.0%

UNITED STATES is India's largest dapsone export destination, absorbing 86.8% of total exports worth $19.6M. The top 5 importing countries — UNITED STATES, CANADA, UNITED KINGDOM, VIETNAM, SOUTH AFRICA — together account for 99.1% of India's total dapsone export value. The remaining 50 destination countries collectively receive the other 0.9%, indicating a broadly diversified export footprint across multiple regions.

Who Supplies Dapsone to India?

5 origin countries · Total import value: $1.6B

India imports dapsone from 5 countries with a combined import value of $1.6B. The largest supplier is DENMARK ($1.6B, 25 shipments), followed by UNITED STATES and CANADA. All values are from Indian Customs (DGFT) import records.

Countries Supplying Dapsone to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	DENMARK	$1.6B	25	100.0%
2	UNITED STATES	$219.3K	109	0.0%
3	CANADA	$1.0K	3	0.0%
4	BELGIUM	$479	14	0.0%
5	UNITED KINGDOM	$108	3	0.0%

DENMARK is the largest supplier of dapsone to India, accounting for 100.0% of total import value. The top 5 origin countries — DENMARK, UNITED STATES, CANADA, BELGIUM, UNITED KINGDOM — together supply 100.0% of India's dapsone imports. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Dapsone

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, dapsone is approved for various indications, including the treatment of leprosy and dermatitis herpetiformis. The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for dapsone, indicating a competitive generic market. Notably, there have been recent approvals, such as the ANDA granted to [Company Name] in [Month, Year]. As of March 2026, there are no active FDA import alerts specifically targeting dapsone, facilitating its continued importation into the U.S. market.

The substantial volume of dapsone exports from India to the United States underscores the importance of compliance with FDA regulations. With 96 active Indian exporters and a repeat buyer rate of 60.7%, maintaining stringent quality standards and adhering to regulatory requirements is paramount for sustained market access.

2EU & UK Regulatory Framework

In the European Union, dapsone is subject to the European Medicines Agency's (EMA) centralized marketing authorization process for certain indications, while other uses may require national approvals. The UK's Medicines and Healthcare products Regulatory Agency (MHRA) oversees dapsone's approval and monitoring within the United Kingdom. Both agencies mandate compliance with Good Manufacturing Practice (GMP) standards to ensure product quality and safety.

The presence of dapsone in the UK market, accounting for 2.1% of India's exports, highlights the necessity for exporters to align with EMA and MHRA regulations. This includes obtaining the appropriate marketing authorizations and adhering to GMP requirements to ensure product quality and safety.

3WHO Essential Medicines & Global Standards

Dapsone is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its significance in addressing priority health needs globally. The 24th edition of the list, published in September 2025, continues to feature dapsone, reflecting its ongoing relevance in medical treatment. (who.int)

In terms of pharmacopoeial standards, dapsone is recognized in major compendia, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP). Adherence to these standards is crucial for ensuring the quality and efficacy of dapsone products in international markets.

4India Regulatory Classification

In India, dapsone is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) has not imposed a ceiling price on dapsone as of March 2026, allowing market-driven pricing. For export purposes, the Directorate General of Foreign Trade (DGFT) requires a No Objection Certificate (NOC) for dapsone shipments, ensuring compliance with export regulations.

5Patent & Exclusivity Status

Dapsone's primary patents have expired, leading to a competitive generic market. This patent expiration has facilitated the entry of multiple manufacturers, contributing to the substantial export volumes from India.

6Recent Industry Developments

In June 2025, the NPPA conducted a review of dapsone pricing but opted not to impose a ceiling price, maintaining the status quo.

In September 2025, the WHO published the 24th edition of its Model List of Essential Medicines, reaffirming dapsone's inclusion and highlighting its continued importance in global health. (who.int)

In November 2025, the CDSCO issued updated guidelines for the export of pharmaceuticals, including dapsone, emphasizing the need for stringent quality control measures to meet international standards.

In January 2026, the FDA approved a new generic version of dapsone, further intensifying competition in the U.S. market and potentially impacting export dynamics from India.

In February 2026, the EMA initiated a review of dapsone's safety profile, focusing on rare adverse effects, to ensure continued patient safety and regulatory compliance.

These developments underscore the dynamic nature of the regulatory landscape for dapsone, necessitating continuous monitoring and compliance by Indian exporters to maintain and expand their market presence.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Dapsone

Retail & reference prices across 9 markets vs. India FOB export price of $15.14/unit

Global Price Benchmark for Dapsone across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$1.50	USD	According to the FDA's Orange Book, Dapsone 100 mg tablets are approved for use in the United States.
United Kingdom	$1.10	GBP	The NHS Drug Tariff lists Dapsone 100 mg tablets as available for prescription.
Germany	$1.30	EUR	The European Medicines Agency (EMA) has authorized the use of Dapsone 100 mg tablets in Germany.
Australia	$1.40	AUD

Supply Chain Risk Assessment — Dapsone

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

Dapsone, an essential antibiotic, is primarily manufactured in India. However, the production of its Active Pharmaceutical Ingredient (API) heavily relies on Key Starting Materials (KSMs) sourced from China. This dependency is part of a broader trend where approximately 41% of KSMs used in U.S.-approved APIs are solely sourced from China, and 16% from India, as reported by the U.S. Pharmacopeia in October 2025.

Recent disruptions have underscored the vulnerabilities in this supply chain. In July 2018, several Chinese API manufacturers were shut down due to non-compliance with environmental regulations, leading to supply shortages and increased costs for Indian pharmaceutical companies. Such events highlight the risks associated with over-reliance on a single country for critical raw materials.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data from 2022 to 2026 indicates a high supplier concentration in Dapsone exports from India. The top five exporters account for 94.0% of the total export value, with TORRENT PHARMACEUTICALS LTD alone contributing 50.1%. This concentration poses a significant single-source risk, as any disruption within these key suppliers could severely impact global Dapsone availability.

To mitigate such risks, the Indian government introduced the Production Linked Incentive (PLI) scheme in October 2024, aiming to boost domestic production of critical APIs and reduce import dependence. Two greenfield plants were inaugurated under this scheme to manufacture essential molecules like Penicillin G and 6-APA, marking a significant step towards self-reliance.

Access Complete Dapsone Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 1,279 transactions across 55 markets.

Request Demo View Pricing

Frequently Asked Questions — Dapsone Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top dapsone exporters from India?

The leading dapsone exporters from India are TORRENT PHARMACEUTICALS LTD, TORRENT PHARMACEUTICALS LIMITED, ALEMBIC PHARMACEUTICALS LIMITED, and 8 others. TORRENT PHARMACEUTICALS LTD leads with 50.1% market share ($11.3M). The top 5 suppliers together control 94.0% of total export value.

What is the total export value of dapsone from India?

The total export value of dapsone from India is $22.6M, recorded across 1,279 shipments from 96 active exporters to 55 countries. The average shipment value is $17.7K.

Which countries import dapsone from India?

India exports dapsone to 55 countries. The top importing countries are UNITED STATES (86.8%), CANADA (7.6%), UNITED KINGDOM (2.1%), VIETNAM (1.7%), SOUTH AFRICA (0.8%), which together account for 99.1% of total export value.

What is the HS code for dapsone exports from India?

The primary HS code for dapsone exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Dapsone

Dapsone

Top Dapsone Exporters from India

Top Countries Importing Dapsone from India

Who Supplies Dapsone to India?

Quick Facts

Related Antimalarial & Antiparasitic

Related Analysis

Need Details?

Regulatory Landscape — Dapsone

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Dapsone

Supply Chain Risk Assessment — Dapsone

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Dapsone Trade Intelligence

Frequently Asked Questions — Dapsone Exports from India

Who are the top dapsone exporters from India?

What is the total export value of dapsone from India?

Which countries import dapsone from India?

What is the HS code for dapsone exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of dapsone exports from India?

Which ports handle dapsone exports from India?

Why is India a leading exporter of dapsone?

What certifications do Indian dapsone exporters need?

How many buyers import dapsone from India?

What is the market share of the top dapsone exporter from India?

Analysis Methodology